My Top Biotech Stock Idea (Inside) Shows Breakout Potential For Monday

SmallCapFirm

PHBI - My No. 1 Biotech Stock For 2020

Multiple Catalysts Could Provide Fuel For This Profile's Immediate Launch (Key Details Below)

December 15th

SCF Members,

Now is the time to turn your full attention to a new breakout stock idea: Pharmagreen Biotech (Ticker: PHBI).

Pharmagreen is a biotech sciences company with specialized products and services in the can*nab*is ("CB") industry.

Like several of your previous triple-digit intraday runners over the past month, PHBI has very few shares available for trading.

Currently, OTCMarkets.com reports PHBI to have a minuscule 2.2Mn unrestricted shares.

Volatility could become a major player if certain catalysts drive momentum into this stock profile.

In fact, 3 specific catalysts highlighted in Thursday's PHBI press release could lead to this stock's immediate breakout. Read them below:

3 Catalysts Providing Significant Potential PHBI Growth

From Thursday 12/12's PR:

CARSON CITY, NV, Dec. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to provide a company development update. The company has secured significant credit facility to date and plans to use the funds to move forward with its projects development to build a state of the art all year round greenhouse and a tissue cultured starter plantlet production facility. The all year round greenhouse was added to the company’s plans for a first build out as time to complete construction is less than six months and revenue producing within 3 months of operations. The greenhouse will allow the company to earn revenues while the tissue culture facility is under construction.

-----

Important Catalyst Takeaways From PHBI's Press Release

#1. Securing a substantial line of credit, PHBI will look to push forward its company's growth plan.

#2. Development plans of their 24/7/365 production facility are in motion.

#3. When PHBI completes construction of the greenhouse in 6 months, it will only take an additional 3 months to start earning revenues.

Rated as my Number #1 Biotech profile, you can now see why I've given PHBI this label...

KEY DETAIL - The Pharmagreen Botany Centre is dedicated to breaking boundaries to become the most internationally recognized and valued biotech science solutions company in North America for its proprietary micro-propagation techniques, tissue culture plantlets production, research and development for plants sustainability, preservation of genetics, extraction of botanical oils, CB products development and plant DNA species identification and certification center.

To wrap it up and put a bow on it, Pharmagreen is a science driven and backed company that views their produced products as unparalleled.

Pharmagreen's model is to provide the hemp farmers the highest quality starter female plantlets to produce the highest quality biomass for the production of CB formulations for human and animal use.

Pharmagreen's ability to supply high CB starter plantlets paired with high level of expertise in farming the strain provides a very lucrative, high CB hemp farming opp. for farmers by making highly efficient use of land.

Now, here's the best part...

IMPORTANT - Greater revenue and higher yields can be generated from 10 acres with Pharmagreen's high CB strain and farming techniques than from farming 1,000 acres using standard industrial hemp from seed.

If you just scanned that last paragraph, you need to go back. That info is bonkers!

By the way, did you know: The global industrial hemp market is projected to grow from $4.6Bn USD in 2019 to $26.6Bn USD by 2025, recording a CAGR of 34%.

With that type of growth potential in the global industrial hemp market, wouldn't farmers looking to produce CB from hemp want to maximize their output and product quality while minimizing the amount of land they use for their crops?

If you said no to that question, you might need have your head examined!

That's why I think that PHBI is currently flying under-the-radar and could be the next big breakout idea within the "Green Wave" movement.

-----

2 More Catalysts That Could Send PHBI Shares Soaring In The Near-term

No. 1. (10/4/19) Pharmagreen Biotech is Seeking to Revolutionize Cancer Research and More with Their Botany Center

The CB industry is worth billions, and is showing no signs of slowing down with many CB related companies now providing crowdfunding investment opp's to both accredited and non-accredited inve*stors who wish to participate in its growth. It may also help discover cures and treatments for cancer. Pharmagreen Biotech, with their S1 document now effective from the SEC, is one such company targeting cancer research and much more with their vision of multi-purpose CB Botany Centers.

No. 2. (9/24/19) Pharmagreen Signs a LOI for Supply of CB Dana Hemp Starter Plantlets

Pharmagreen Biotech, Inc. is pleased to announce that its Canadian subsidiary, WFS Pharmagreen Inc., has signed a Letter of Intent with Carpere Inc. for the supply of “CB Dana” hemp starter plantlets for the 2020 farming season and beyond.

The Pharmagreen team is excited to work with Carpere to be their supplier of all female high CB hemp starter plantlets to produce the highest quality high CB flower tops as well as production of the CB whole hemp oils and isolate. Carpere owns and manages farmland, on behalf of farmers, in excess of 100,000 acres throughout Canada.

PHBI Services Provide Clear Picture For Market Domination

PLANT TISSUE CULTURE UNIT

CHIBAFREEN™ a new, highly evolved, state-of-the art in vitro plant production method is introduced by the company Botanical Research In Motion Inc. (B.R.I.M.) for exclusive use by WFS Pharmagreen Inc. for various kinds of high quality transplant production in the company’s Botany Center.

This proprietary process was developed by Dr. Fawzia Afreen.

In this method relatively small chlorophyllous (leafy) explants or single nodal cuttings are grown inside the culture vessel under pathogen free, sterile condition under artificial light.

The conventional in vitro system for transplant production involves four stages:

1) Initiation, 2) Multiplication, 3) Rooting and 4) Hardening.

In their new method one of the stages is eliminated, which reduce the production period and costs drastically. The root formation and the hardening of the plant are carried out using their new technology, coined as Chibafreen™ in vitro plant production. The CB Botany Center will produce approximately 10Mn plantlets at full capacity.

DNA TESTING SERVICES UNIT

Using DNA testing, growers can ensure they have the right genetics of plants to grow:

protect their crops from uncertified plant species investment mitigate the risk of plant to yield ratios
reduce losses from environmental conditions
protect them from any financial damage

No other DNA commercial facility is in operation west of Manitoba.

Saskatchewan Research Council (SRC’s ) Biotechnology Laboratories exists for scientific purposes only. B.R.I.M. will use SSR marker (Simple sequence repeat) technology to fingerprint varieties. We will develop an extensive database for several crops. Clients/growers simply need to collect leaf samples (300 – 500 g) of a suspect variety and our lab will compare its SSR fingerprint to varieties in our database. These services will be provided by B.R.I.M. as a value-added service for Pharmagreen’s Botany Center.

COLD STORAGE UNIT

Lowering temperature can slow the metabolic processes (e.g. respiration) and prevent undesirable loss of dry mass and associated deteriorations of quality. The proper combination of air temperature, light intensity and propriety techniques during storage would contribute to minimizing increase/decrease in dry weight and preserving photosynthetic ability and provide immediate regrowth of plantlets after storage.

First of its kind service for:

To preserve clients plants strains and propagate them when necessary.
To maintain a variety of plants species indefinitely with the immediate ability for mass reproduction.
Flexible production schedule on a commercial scale is possible.

NURSERY UNIT

Year-round greenhouse structures will be built on the property to provide nursery service for CB plants inclusive of indica, sativa and hemp strains for the CB cultivators. The company will be working closely with industrial hemp farmers for the production of hemp strains with high CB content. B.R.I.M. Inc. has completed successful research on its high CB strain dubbed “CB DANA” which content is well over 10% in CB and the THC at below .03% which makes it ideal for industrial hemp farming.

“CB DANA” will be available for sale exclusively through Pharmagreen’s CB Botany Center.

EXTRACTION UNIT

Extraction service for CB plant oils will be provided for all clients as well as for future production of Pharmagreen brands of CB products for human use. Additionally, B.R.I.M. will be conducting research and development of CB formulations for Pharmagreen brands.

The extraction and distillation equipment will be certified medical grade equipment with a capacity for commercial scale production.

https://www.pharmagreen.ca

-----

Monday's opening bell is right around the corner. PHBI is my top Biotech stock going into 2020. Get it on your radar now.

To Your Trading Success,

Axel Adams

Editor, SCF

(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

Disclosure: Make sure to always do your own research and due diligence on any day and swing trade profile I bring to your attention. I am not a license d finan.cial advise r. All potential percentage gains are based on from the low to the high of day. SmallCapFirm's full disclosure is to be read and fully understood before using SmallCapFirm's website, or joining SmallCapFirm's email or text list. By viewing SmallCapFirm's website and/or reading SmallCapFirm's email or text newsletter you are agreeing to SmallCapFirm's full disclosure which can be read at: smallcapfirm.com/disclosure Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com ("SCF") and an interest in the limited liability company that owns and operates fierce analyst . com ("FI"). From time to time, non-affiliated third parties hire Stock Wire News, SCF and/or FI jointly to publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between SmallCapFirm and StockWireNews LLC, (a non affiliated 3rd party), SmallCapFirm has been hired for a period beginning on 10/14/19 and ending on 10/15/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid five thousand USD via bank wire transfer. We own zero shares of (PHBI). A member of StockWireNews LLC owns an interest in SmallCapFirm. Pursuant to an agreement between StockWireNews LLC and Awareness Consulting Network LLC (a non affiliated 3rd party), StockWireNews has been hired for a period beginning on 10/14/19 and ending on 10/15/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid thirty thousand USD via bank wire transfer. We own zero shares of (PHBI). Pursuant to an agreement between SmallCapFirm and StockWireNews LLC, (a non affiliated 3rd party), SmallCapFirm has been hired for a period beginning on 12/13/19 and ending on 12/16/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid five thousand USD via bank wire transfer. We own zero shares of (PHBI). To date, we have been compensated a total of ten thousand USD via bank wire transfer to disseminate information about (PHBI). A member of StockWireNews LLC owns an interest in SmallCapFirm. Pursuant to an agreement between StockWireNews LLC and Awareness Consulting Network LLC (a non affiliated 3rd party), StockWireNews has been hired for a period beginning on 12/13/19 and ending on 12/16/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid thirty thousand USD via bank wire transfer. We own zero shares of (PHBI). To date, we have been compensated a total of sixty thousand USD via bank wire transfer to disseminate information about (PHBI).